Canopy Growth Corporation (CGC) concluded trading on Wednesday at a closing price of $2.83, with 4.87 million shares of worth about $13.8 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -60.25% during that period and on December 18, 2024 the price saw a loss of about -7.21%. Currently the company’s common shares owned by public are about 101.58M shares, out of which, 100.82M shares are available for trading.
Stock saw a price change of -13.72% in past 5 days and over the past one month there was a price change of -25.33%. Year-to-date (YTD), CGC shares are showing a performance of -44.62% which decreased to -42.06% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.76 but also hit the highest price of $14.92 during that period. The average intraday trading volume for Canopy Growth Corporation shares is 5.55 million. The stock is currently trading -20.41% below its 20-day simple moving average (SMA20), while that difference is down -31.16% for SMA50 and it goes to -54.38% lower than SMA200.
Canopy Growth Corporation (NASDAQ: CGC) currently have 101.58M outstanding shares and institutions hold larger chunk of about 9.25% of that.
The stock has a current market capitalization of $287.47M and its 3Y-monthly beta is at 0.83. It has posted earnings per share of -$4.94 in the same period. It has Quick Ratio of 1.07 while making debt-to-equity ratio of 1.20. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CGC, volatility over the week remained 5.50% while standing at 5.80% over the month.
Stock’s fiscal year EPS is expected to rise by 60.79% while it is estimated to increase by 74.90% in next year. EPS is likely to grow at an annualized rate of 35.49% for next 5-years, compared to annual growth of 20.88% made by the stock over the past 5-years.
Coverage by Bernstein stated Canopy Growth Corporation (CGC) stock as an Underperform in their note to investors on November 02, 2022, suggesting a price target of $1.50 for the stock. Stock get an Underweight rating from Barclays on March 22, 2022.
